Patriot Scientific

Patriot Scientific Reports Profitable Quarter; Q3 FY '08 Net Income $6.3 Million or $0.02 Basic and Diluted Earnings Per Share.
3
1
Re: B-Lunist
about 15 years ago
7
7
8
SGE....
over 14 years ago
6
Re: SGE....
over 14 years ago
6
11
6
13
in response to ronran's message

We both know that the BoD have no control over licensing, so the onus remains with Alliacense to react to any '336 update.

Why does the fact that there is no consistent revenue stream for which to predict future revenues never enter into the berate-the-BoD-for-everything farrago?

If the BoD can't know or predict from month-to-month what revenues to expect, how can one seriously expect the investment community to do other than let the price stagnate?

Changing the incumbent BoD will do absolutely nothing for the share price without the benefit of a predictable revenue, not now, not then, nor in the future. I humbly suggest that it was, in the main, the expectation of a constant flow of revenues which drove the price above $2, on all sides.

What followed is history, not incompetence.

By all means, please take it as a given that all my posts conclude with "BRING IT ON" without my need to repeat it.

.

.

.

Be well

Please login to post a reply
milestone
City
Rank
President
Activity Points
18650
Rating
Your Rating
Date Joined
08/04/2005
Social Links
Private Message
Patriot Scientific
Symbol
PTSC
Exchange
OTCBB
Shares
401,392,948
Industry
Technology & Medical
Website
Create a Post